Keep Up With McLean!
Receive the latest news in your inbox each month.
This panel discussion was part of the 2017 Technology in Psychiatry Summit, sponsored by the McLean Institute for Technology in Psychiatry on November 6-7, 2017, at the JB Martin Conference Center, Harvard Medical School. Part of panel: From Insights to Actions: Strategies for Care Transformation.
Digital technologies have the potential to transform mental health care, particularly among groups that have traditionally been hard to reach due to lack of access, education, or resources. In this session, leading experts in technology, policy, and public health discuss how we might take the insights generated from clinical and basic research and translate them to improvements in care and access to care. Discussion focuses on how to address the gap between the availability of mental health services and the pressing need for such services globally.
Ken Duckworth, MD, is the medical director for behavioral health at BCBSMA and an assistant professor of psychiatry at Harvard Medical School. He is the former acting commissioner of mental health for Massachusetts and also was the state medical director. He is the medical director for NAMI, the National Alliance on Mental Illness.
Oliver Harrison, MD, MPH, is CEO of Alpha Health, Telefonica Alpha’s first Moonshot, which is on a five-year journey to transform health by addressing human behavior. Before Alpha, Oliver held positions at Healthways, the government of Abu Dhabi, and McKinsey’s healthcare practice. Oliver has faculty appointments at both Imperial College and Johns Hopkins University.
Gary Gottlieb, MD, is CEO of Partners in Health, a provider of healthcare in some of the world’s poorest countries. He previously served as CEO of Partners HealthCare, president of Brigham and Women’s Hospital, chair of Partners Psychiatry, and interim president of McLean Hospital. He is a professor of psychiatry at Harvard Medical School, a member of the National Academy of Medicine, chair of the Federal Reserve Bank of Boston, an executive partner at Flare Capital Partners, and a member of the boards of health tech companies Kyruus and OM1.
Kimberlyn Leary, PhD, MPA, is an associate professor of health policy and management, and program director of Enabling Change at the Harvard T.H. Chan School DrPH Program, an associate professor of psychology in the Department of Psychiatry at Harvard Medical School, consultant for the Center of Excellence in Women’s Mental Health at McLean Hospital, a faculty affiliate at the Program on Negotiation at Harvard Law School, and senior advisor to the CEO at the National Math and Science Initiative.
Shelly F. Greenfield, MD, MPH, is an addiction psychiatrist, clinician, and researcher. She serves as principal and co-investigator on federally funded research focusing on substance use disorders treatment, gender differences, and substance health services. Dr. Greenfield is a member of the Board of Directors of the American Academy of Addiction Psychiatry and the American Psychiatric Association’s Council on Addiction Psychiatry, and chair of the NIDA Clinical Trial Network’s Gender Special Interest Group. She is editor in chief of the Harvard Review of Psychiatry, a distinguished fellow of the American Psychiatric Association, and is the recipient of numerous awards including McLean’s Jack H. Mendelson Memorial Award for Research and the R. Brinkley Smithers Distinguished Scientist Award from the American Society of Addiction Medicine.
Please visit mclean.org/itp to learn more about the McLean Institute for Technology in Psychiatry.
Back to top